drugset / Trial / NCT00422032

2 Arm Study of Clofarabine IV in MDS Patients

NCT00422032

RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to compare the effectiveness of 2 different doses of the drug clofarabine that can be given on a weekly schedule for the treatment of Myelodysplastic Syndrome (MDS). The safety of these two doses will also be compared. Primary Objective: Compare the response rates of two dose schedules of clofarabine in MDS. Secondary Objective: Compare response durations, survivals and side effects of the two schedules.

Timeline

Start
2006-01
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Clofarabine Other / unclassified 15 mg/m2 Intravenous
Subject Clofarabine Other / unclassified 30 mg/m2 Intravenous